VANCOUVER, Aug. 28 /CNW/ - iCo Therapeutics Inc. (TSX-V: ICO) today
reported interim financial results (unaudited) for the three and six months
ended June 30, 2008. Amounts, unless specified otherwise, are expressed in
Canadian dollars and in accordance with Canadian Generally Accepted Accounting
Principles (Canadian GAAP).
